Skip to main content

Advertisement

SpringerLink
Log in

Syringe-Mediated Syndemics

  • Commentary
  • Published:
AIDS and Behavior Aims and scope Submit manuscript

Abstract

One consequence of the global HIV/AIDS pandemic has been the emergence of a broad awareness of the potential role of syringes in the transmission of infectious diseases. In addition to HIV/AIDS, the use of unsterile syringes by multiple persons has been linked to the spread of Hepatitis B, Hepatitis C, Leishmaniasis, malaria and various other infections. The purpose of this paper is to extend awareness of the grave risks of multiperson syringe use by examining the role of this behavior in the development of infectious disease syndemics. The term syndemics refers to the clustering, often due to noxious social conditions, of two or more diseases in a population resulting in adverse disease synergies that impact human life and well-being. The contemporary appearance and spread of identified syringe-mediated syndemics, and the potential for the emergence of future syringe-mediated syndemics, both of which are reviewed in this paper, underline the importance of public health measures designed to limit syringe-related disease transmission.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Grund JP, Friedman S, Stern L, et al. Syringe-mediated drug sharing among injecting drug users: patterns, social context and implications for transmission of blood-borne pathogens. Soc Sci Med. 1996;4(5):691–703.

    Article  Google Scholar 

  2. Hagen H, Des Jarlias D. HIV and HCV infection among injecting drug users. J Mt Sinai Hosp N Y. 2000;67(5&6):423–8.

    Google Scholar 

  3. Stimson G, Des Jarlais D, Ball A. Drug injecting and HIV infection: global dimensions and local responses. New York: Routledge; 1998.

    Google Scholar 

  4. Frischer M. Mobility and the Diffusion of Drug Injecting and HIV Infection. In: Stimson G, Des Jarlais D, Ball A, editors. Drug injecting and HIV infection: global dimensions and local responses. New York: Routledge; 1998. p. 101–14.

    Google Scholar 

  5. Reid S. Injection drug use, unsafe medical injections, and HIV in Africa: a systematic review. Harm Reduct J. 2009;6(1):24. Epub ahead of print.

    Article  PubMed  Google Scholar 

  6. Singer M. Something dangerous: emergent and changing illicit drug use and community health. Prospect Heights, IL: Waveland Press; 2006.

    Google Scholar 

  7. Ball A, Rana S, Dehne K. HIV prevention among injecting drug users: responses in developing and transitional countries. Public Health Rep. 1998;113(Suppl 1):170–81.

    PubMed  Google Scholar 

  8. McCoy C, Rodríguez F. Global overview of injecting drug use and HIV infection. Lancet. 2005;365(9464):1008–9.

    PubMed  Google Scholar 

  9. Stimson G, Adelekan M, Rhodes T. The diffusion of drug injecting in developing countries. Int J Drug Policy. 1996;7:245–55.

    Google Scholar 

  10. Bastos F, Barcellos C, Lowndes C, Friedman S. Co-infection with malaria and HIV in injecting drug users in Brazil: a new challenge to public health? Addiction. 1999;94:1165–74.

    Article  PubMed  CAS  Google Scholar 

  11. Sharp CP, Lail A, Donfield S, et al. High frequencies of exposure to the novel human parvovirus PARV4 in hemophiliacs and injection drug users, as detected by a serological assay for PARV4 Antibodies. J Infect Dis. 2009;200(7):1119–25.

    Article  PubMed  CAS  Google Scholar 

  12. Stark K, Bienzle U, Vonk R, Guggenmoos-Holzmann I. History of syringe sharing in prison and risk of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection among injecting Drug uses in Berlin. Int J Epidemiol. 1997;26(6):1359–66.

    Article  PubMed  CAS  Google Scholar 

  13. Todd C, Abed A, Strathdee S, et al. HIV, hepatitis C, and hepatitis B infections and associated risk behavior in injection drug users, Kabul, Afghanistan. Emerg Infect Dis. 2007;13(9):1327–31.

    PubMed  Google Scholar 

  14. Molina R, Gradoni L, Alvar J. HIV and the transmission of Leishmania. Ann Trop Med Parasitol. 2003;97(S1):S29–45.

    Article  Google Scholar 

  15. Xia X, Luo J, Bai J, Yu R. Epidemiology of hepatitis C virus infection among injection drug users in China: systematic review and meta-analysis. Public Health. 2008;122(10):990–1003.

    Article  PubMed  Google Scholar 

  16. Miller CL, Wood E, Spittal PM, et al. The future face of coinfection: prevalence and incidence of HIV and hepatitis C virus coinfection among young injection drug users. J Acquir Immune Defic Syndr. 2004;36(2):743–9.

    Article  PubMed  Google Scholar 

  17. Dumchev KV, Soldyshev R, Qian HZ, et al. HIV and hepatitis C virus infections among hanka injection drug users in central Ukraine: a cross-sectional survey. Harm Reduct J. 2009;6(1):23. Epub ahead of print.

    Article  PubMed  Google Scholar 

  18. Antonucci G, Vairo F, Iacomi F, et al. Role of hepatitis B virus, hepatitis D virus and other determinants on suppression of hepatitis C viraemia in HIV infected patients with chronic HCV infection: a longitudinal evaluation. Scand J Infect Dis. 2008;40(11–12):928–34.

    Article  PubMed  CAS  Google Scholar 

  19. Singer M. Introduction to syndemics: a systems approach to public and community health. San Francisco, CA: Jossey-Bass; 2009.

    Google Scholar 

  20. Inciardi J. The war on drugs: heroin, cocaine, crime, and public policy. Mountain View, California: Mayfield; 1986.

    Google Scholar 

  21. Bradley J. Transmission of malaria in drug addicts by intravenous use of narcotics. Am J Trop Med. 1934;14(4):319–24.

    CAS  Google Scholar 

  22. Derricott J. The history of injecting and needle exchange. 1999. Available at: http://www.drugtext.org/library/books/needle/historym.htm. Accessed 31 Aug 2009.

  23. Page JB, Smith P, Kane N. Shooting galleries, their proprietors, and implications for prevention of AIDS. Drugs Soc (New York). 1990;5(1–2):69–85.

    Google Scholar 

  24. van Staa AL, Hardon A. Injection practices in the developing world results and recommendations from field studies in Uganda and Indonesia. Amsterdam: Medical Anthropology Unit, University of Amsterdam; 1996.

    Google Scholar 

  25. Wyatt H. The popularity of injections in the third world: origin and consequences for poliomyelitis. Soc Sci Med. 1984;19(9):911–5.

    Article  PubMed  CAS  Google Scholar 

  26. Singer M. Pathogen-pathogen interaction: a syndemic model of complex biosocial processes in disease. Virulence 2010; 1(1).

  27. Mustanski B, Garofalo R, Herrick A, Donenberg G. Psychosocial health problems increase risk for HIV among urban young men who have sex with men: preliminary evidence of a syndemic in need of attention. Ann Behav Med. 2007;34(1):37–45.

    Article  PubMed  Google Scholar 

  28. Singer M. Pathogens gone wild?: medical anthropology and the “swine flu” pandemic. Med Anthropol. 2009;28(3):199–206.

    Article  PubMed  Google Scholar 

  29. Herring DA, Sattenspiel L. Social contexts, syndemics, and infectious disease in northern aboriginal populations. Am J Hum Biol. 2007;19(2):190–202.

    Article  PubMed  Google Scholar 

  30. Singer M, Clair S. Syndemics and public health: reconceptualizing disease in bio-social context. Med Anthropol Q. 2003;17(4):423–41.

    Article  PubMed  Google Scholar 

  31. Fleming A, Ogilvie AC. Syringe needles and mass inoculation technique. Br Med J. 1951;1(4706):543–6.

    Article  PubMed  CAS  Google Scholar 

  32. Chaisson R, Bachetti P, Osmond D, Brodie B, Sande M, Moss A. Cocaine use and HIV infection in intravenous drug users in San Francisco. J Am Med Assoc. 1989;261(4):61–5.

    Article  Google Scholar 

  33. Thompson SC, Boughton CR, Dore GJ. Bloodborne viruses and their survival in the environment: is public concern about community needlestick exposures justified? Aust N Z J Public Health. 2003;27(6):602–7.

    Article  PubMed  Google Scholar 

  34. Simonsen L, Kane A, Lloyd J, Zaffran M, Kane M. Unsafe injections in the developing world and transmission of bloodborne pathogens: a review. Bull World Health Organ. 1999;77(10):789–800.

    PubMed  CAS  Google Scholar 

  35. Singh J, Bhatia R, Gandhi JC, et al. Outbreak of viral hepatitis B in a rural community in India linked to inadequately sterilized needles and syringes. Bull World Health Organ. 1998;76(1):93–8.

    PubMed  CAS  Google Scholar 

  36. Frank C et al. The role of antischistosomal mass injection treatment in the spread of hepatitis C virus infection in Egypt. Paper presented at: International conference on emerging infectious diseases, Atlanta, 8–11 March, 1998.

  37. World Health Organization. Expanded programme on immunization—changing needles but not the syringe: an unsafe practice. Wkly Epidemiol Rec. 1987;62:345–52.

    Google Scholar 

  38. Luby SP, Qamruddin K, Shah AA, et al. The relationship between therapeutic injections and higher prevalence of Hepatitis C in Hafizabad, Pakistan. Epidemiol Infect. 1997;199(3):349–56.

    Article  Google Scholar 

  39. Hagan H. Hepatitis C virus transmission dynamics in injection drug users. Subst Use Misuse. 1998;33(5):1197–212.

    Article  PubMed  CAS  Google Scholar 

  40. Chang CJ, Lin CH, Lee CT, Chang SJ, Ko YC, Liu HW. Hepatitis C virus infection among short-term intravenous drug users in southern Taiwan. Eur J Epidemiol. 1999;15(7):597–601.

    Article  PubMed  CAS  Google Scholar 

  41. Hersh BS, Popovici F, Jezek Z, et al. Risk factors for HIV infection among abandoned Romanian children. AIDS. 1993;7(12):1617–24.

    Article  PubMed  CAS  Google Scholar 

  42. Christensen C. Cluster of HIV-1 infection among children in Indian Hospital in Bombay. Informal report to WHO, September 1998. Copenhagen: Department of Virology, Statens Serum Institute; 1998.

  43. Des Jarlais D, Arasteh K, Semaan S, Wood E. HIV among injecting drug users: current epidemiology, biologic markers, respondent-driven sampling, and supervised-injection facilities. Curr Opin HIV AIDS. 2009;4(4):308–13.

    Article  PubMed  Google Scholar 

  44. Abulrahi HA, Bohlega EA, Fontaine RE, al-Seghaver SM, al-Ruwais AA. Plasmodium falciparum malaria transmitted in hospital through heparin locks. Lancet. 1997;349(9044):23–5.

    Article  PubMed  CAS  Google Scholar 

  45. Alavi SM, Alavi L, Jaafari F. Outbreak investigation of needle sharing-induced Malaria, Ahvaz, Iran. Int J Infect Dis. 2009; [Epub ahead of print].

  46. Cruz I, Morales MA, Noguer I, Rodriguez A, Alvar J. Leishmania in discarded syringes from intravenous drug users. Lancet. 2002;9312:1124–5.

    Article  Google Scholar 

  47. Lawn SD. AIDS in Africa: the impact of coinfections on the pathogenesis of HIV-1 infection. J Infect. 2004;48:1–12.

    Article  PubMed  CAS  Google Scholar 

  48. World Health Organization, Health Evidence Network. HIV/HCV Coinfection. Updated 05 August 2009. Available at: http://www.euro.who.int/HEN/Syntheses/hepatitisC/20050411_7. Accessed 5 Sep 2009.

  49. van Geertruyden J, D’Alessandro U. Malaria and HIV: a silent alliance. Trends Parasitol. 2007;23:465–7.

    Article  Google Scholar 

  50. Whitworth J, Morgan D, Quigley M, et al. Effect of HIV-1 and increasing immunosuppression on malaria parasitaemia and clinical episodes in adults in rural Uganda: a cohort study. Lancet. 2000;356:1051–6.

    Article  PubMed  CAS  Google Scholar 

  51. Moriuchi M, Moriuchi H, Mon HM, Kanbara H. Dichotomous effects of Plasmodium falciparum antigens on expression of human immunodeficiency virus (HIV) coreceptors and on infectability of CD4 cells by HIV. J Infect Dis. 2002;186(8):1194–7.

    Article  PubMed  CAS  Google Scholar 

  52. den Boer M, Alvar J, Davidson R, Ritmeijer K, Balasegaram M. Developments in the treatment of visceral leishmaniasis. Expert Opin Emerg Drugs. 2009;14(3):395–410.

    Article  Google Scholar 

  53. Oliver M, Bararo R, Medrano F, Moreno J. The pathogenesis of leishmania/HIV co-infection: cellular and immunological mechanisms. Parasitology. 2003;97(Suppl 1):79–98.

    Google Scholar 

  54. Zhao C, Thibault S, Messier N, Ouellette M, Papadopoulou B, Tremblay MJ. In primary human monocyte-derived macrophages exposed to human immunodeficiency virus type 1, does the increased intracellular growth of Leishmaniainfantum rely on its enhanced uptake? J Gen Virol. 2006;87:1295–302.

    Article  PubMed  CAS  Google Scholar 

  55. ter Horst R, Collin SM, Ritmeijer K, Bogale A, Davidson RN. Concordant HIV infection and visceral leishmaniasis in Ethiopia: the influence of antiretroviral treatment and other factors on outcome. Clin Infect Dis. 2008;46:1702–9.

    Article  PubMed  Google Scholar 

  56. Trudel N, Garg R, Messier N, Sundar S, Ouellette M, Tremblay MJ. Intracellular survival of leishmania species that cause visceral leishmaniasis is significantly reduced by HIV-1 protease inhibitors. J Infect Dis. 2008;198:1292–9.

    Article  PubMed  CAS  Google Scholar 

  57. Mathur P, Samantaray JC, Vajpayee M, Samanta P. Visceral leishmaniasis/human immunodeficiency virus co-infection in India: the focus of two epidemics. J Med Microbiol. 2006;55:919–22.

    Article  PubMed  Google Scholar 

  58. Burnet M, White D. Natural history of infectious disease. Cambridge: Cambridge University Press; 1972.

    Google Scholar 

  59. Global Infectious Diseases and Epidemiology Online Network (GIDEON). Emergence of infectious diseases in the 21st Century. 2008. Available at: http://www.gideononline.com/blog/2008/03/05/emergence-of-infectious-diseases-in-the-21st-century/. Accessed 5 Sep 2009.

  60. Woolhouse ME, Gowtage-Sequeria S. Host range and emerging and reemerging pathogens. Emerg Infect Dis. 2005;11(12):1843–7.

    Google Scholar 

  61. Singer M. Drugging the poor: legal and illegal drug industries and the structuring of social inequality. Prospect Heights, IL: Waveland Press; 2008.

    Google Scholar 

  62. McKnight C, Des Jarlais D, Perlis T, et al. Syringe exchange programs—United States, 2005. MMWR Morb Mortal Wkly Rep. 2007;56(44):1164–7.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Anthropology, University of Connecticut, Storrs, CT, 06269-2176, USA

    Nicola Bulled & Merrill Singer

Authors
  1. Nicola Bulled
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Merrill Singer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nicola Bulled.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bulled, N., Singer, M. Syringe-Mediated Syndemics. AIDS Behav 15, 1539–1545 (2011). https://doi.org/10.1007/s10461-009-9631-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10461-009-9631-1

Keywords

Search

Navigation